Copper metabolism: A novel strategy for tumor immunotherapy resistance
International Immunopharmacology · 2026-12 · 190 · 117519
DOI: 10.1016/j.intimp.2026.117519 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026-12. Verfasst von Wenxuan Ji und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China. Hauptthemen laut MEDLINE: Copper, Immunotherapy, Neoplasms. Die Arbeit nennt 150 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Henan Province, The First Affiliated Hospital of Zhengzhou University.
Abstract (Originalsprache)
Copper is an essential nutrient for organisms, and alterations in copper metabolism often indicate a diseased state. Recently, the role of copper metabolism in tumor immunotherapy has garnered increasing attention. Cuproptosis, along with the restoration of dysregulated copper homeostasis, can modulate PD-L1 expression, evoke antitumor immune responses, enhance the infiltration of immune cells into tumors, and reprogram the tumor microenvironment. Therefore, targeting copper metabolism presents a novel strategy to overcome resistance to tumor immunotherapy. In this review, we summarize the fundamental aspects of copper metabolism, the mechanisms underlying cuproptosis and copper homeostasis, the impacts of copper metabolism on the immune system, and the applications of copper-based compounds (including copper chelators, copper ionophores, and copper complex-based agents) and nanoparticles (NPs) in cancer immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.
- National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China.
- Department of Pharmacology, Yong Loo Lin School of Medicine, Singapore. Electronic address: phcgs@nus.edu.sg.
- National Engineering Laboratory for Internet Medical Systems and Applications, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China; Cancer Center, The First Affiliated Hospital of Zheng…
- Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, China; Medical School, Huanghe Science and Technology University, 666 Zi Jing Shan Road, Zhengzhou 450000, Henan, C…
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Henan Province
- The First Affiliated Hospital of Zhengzhou University
- China Postdoctoral Science Foundation
Zitieren
APA
Ji, W., Chen, C., Chao, K., Li, C., Zhu, L., Ge, Y., Sethi, G., Li, L., & Xue, W. (2026). Copper metabolism: A novel strategy for tumor immunotherapy resistance. International Immunopharmacology, 190, 117519. https://doi.org/10.1016/j.intimp.2026.117519
Vancouver
Ji W, Chen C, Chao K, Li C, Zhu L, Ge Y, et al. Copper metabolism: A novel strategy for tumor immunotherapy resistance. International Immunopharmacology. 2026;190:117519. doi:10.1016/j.intimp.2026.117519
BibTeX
@article{Ji2026,
author = {Ji, Wenxuan and Chen, Chengxin and Chao, Ke and Li, Chunwei and Zhu, Lili and Ge, Yahao and Sethi, Gautam and Li, Lifeng and Xue, Wenhua},
title = {Copper metabolism: A novel strategy for tumor immunotherapy resistance},
journal = {International Immunopharmacology},
year = {2026},
volume = {190},
pages = {117519},
doi = {10.1016/j.intimp.2026.117519}
}
EUVIMED